GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Equity-to-Asset

Oncimmune Holdings (LSE:ONC) Equity-to-Asset : -0.22 (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Oncimmune Holdings's Total Stockholders Equity for the quarter that ended in Feb. 2024 was £-1.28 Mil. Oncimmune Holdings's Total Assets for the quarter that ended in Feb. 2024 was £5.95 Mil. Therefore, Oncimmune Holdings's Equity to Asset Ratio for the quarter that ended in Feb. 2024 was -0.22.

The historical rank and industry rank for Oncimmune Holdings's Equity-to-Asset or its related term are showing as below:

LSE:ONC' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.96   Med: 0.08   Max: 0.94
Current: -0.22

During the past 12 years, the highest Equity to Asset Ratio of Oncimmune Holdings was 0.94. The lowest was -1.96. And the median was 0.08.

LSE:ONC's Equity-to-Asset is ranked worse than
86.98% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs LSE:ONC: -0.22

Oncimmune Holdings Equity-to-Asset Historical Data

The historical data trend for Oncimmune Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Equity-to-Asset Chart

Oncimmune Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 Aug23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 -0.02 0.27 -0.16 0.08

Oncimmune Holdings Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 -0.16 -0.77 0.08 -0.22

Competitive Comparison of Oncimmune Holdings's Equity-to-Asset

For the Biotechnology subindustry, Oncimmune Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncimmune Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Equity-to-Asset falls into.



Oncimmune Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Oncimmune Holdings's Equity to Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Equity to Asset (A: Aug. 2023 )=Total Stockholders Equity/Total Assets
=0.657/8.436
=0.08

Oncimmune Holdings's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=-1.277/5.947
=-0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncimmune Holdings  (LSE:ONC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Oncimmune Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncimmune Holdings (LSE:ONC) Business Description

Traded in Other Exchanges
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.

Oncimmune Holdings (LSE:ONC) Headlines

No Headlines